Personalized Medicine: An Update on HER2 Testing

  • Duration: 59 Minutes

Price: $69.00

Member Price: $59.00

Rating: Member Average

This webcast originally aired as a live webinar sponsored by AACC on February 11, 2014. When performing a test for human epidermal growth factor receptor 2 (HER2) to determine if a woman has this aggressive form of breast cancer, what’s the best way to respond to an equivocal result? This is one of the challenges in HER2 testing that the 2013 guideline update from the American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) seeks to address, but there are also other nuances involved in HER2 testing that laboratorians must understand. After viewing this program, you will know: what role anti-HER2 therapy plays in the treatment of breast cancer; the advantages and limitations of current HER2 testing technologies; what the 2013 ASCO/CAP HER2 Clinical Practice Guideline update recommends; and what the update means for clinical labs.